# US 2013/0231733 A1 · Biocompatible surfaces and devices incorporating such surfaces

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0231733 A1
- Document ID: US20130231733A1
- Status: Published application
- Kind: A1
- Application number: 13/773,937
- Filed: 2013-02-22
- Published: 2013-09-05
- Earliest claimed: 2012-03-02
- Assignees: W. L. Gore & Associates, Inc.
- Applicants: W. L. Gore & Associates, Inc.
- Inventors: KEITH A. KNISLEY; VISHNU T. MARLA; RACHEL RADSPINNER; PAUL A. SILVAGNI; JASON J. STRID; MICHAEL J. VONESH
- Web page: https://patentgrep.com/patent/US20130231733A1

## CPC

- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61F 2/0077: {Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence)}
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 33/007: {Porous materials, e.g. foams or sponges}
- A61L 33/064: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L33/062 takes precedence)}
- A61F 2002/009: {for hindering or preventing attachment of biological tissue}
- A61L 2300/416: Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A61L 2300/42: Anti-thrombotic agents, anticoagulants, anti-platelet agents
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The invention is an improved biocompatible surface for a variety of medical purposes. The biocompatible surface employs a unique tight microstructure that demonstrates enhanced cellular response in the body, particularly when placed in contact with blood. As a blood contact surface, the present invention can be beneficially employed in a wide variety of implantable devices and in many other devices and equipment that come in contact with blood.

## Claims

### Claim 1

A blood contact surface comprising
a polytetrafluoroethylene microstructure of nodes and fibrils in both an x direction and in a substantially perpendicular y direction;
wherein the nodes and fibrils have a mean distance between adjacent nodes of 5 micron or less; and
wherein the mean width of the 32 largest nodes in a representative 10,000×SEM micrograph is less than about 1.5 micron.

### Claim 2 (depends on 1)

The blood contact surface of claim 1 wherein the nodes and fibrils have a ratio of mean distances between adjacent nodes in the x and y directions of about 2:1 to 1:1.

### Claim 3 (depends on 2)

The blood contact surface of claim 2 wherein the ratio of mean distances between adjacent nodes in the x and y directions is about 1:1.

### Claim 4 (depends on 1)

The blood contact surface of claim 1 wherein the expanded polytetrafluoroethylene comprises a multi-axially expanded polytetrafluoroethylene.

### Claim 5 (depends on 4)

The blood contact surface of claim 4 wherein the expanded polytetrafluoroethylene comprises a bi-axially expanded polytetrafluoroethylene.

### Claim 6 (depends on 1)

The blood contact surface of claim 1 wherein the expanded polytetrafluoroethylene comprises fibrils extended outwardly from the nodes in substantially perpendicular directions.

### Claim 7 (depends on 1)

The blood contact surface of claim 1 wherein the mean width of the nodes comprises less than about 1.25 micron.

### Claim 8 (depends on 1)

The blood contact surface of claim 1 wherein the mean width of the nodes is less than about 1 micron.

### Claim 9 (depends on 1)

The blood contact surface of claim 1 wherein the ratio of mean distances between adjacent nodes in the x and y directions is less than 1.5 to 1.

### Claim 10 (depends on 1)

The blood contact surface of claim 1 wherein the microstructure substantially prevents cellular in-growth.

### Claim 11 (depends on 1)

The blood contact surface of claim 1 wherein the blood contact surface is incorporated in an implantable medical device.

### Claim 12 (depends on 1)

The blood contact surface of claim 1 wherein the blood contact surface is incorporated in a non-implantable medical device.

### Claim 13 (depends on 1)

The blood contact surface of claim 1 wherein the mean distance between adjacent nodes is less than about 4 micron.

### Claim 14 (depends on 13)

The blood contact surface of claim 13 wherein the mean distance between adjacent nodes is less than about 3 micron.

### Claim 15 (depends on 11)

The blood contact surface of claim 11 wherein the implantable medical device includes a stent.

### Claim 16 (depends on 1)

The blood contact surface of claim 1 wherein endothelial cells attach intimately to the node and fibril microstructure.

### Claim 17

A blood contact surface comprising
a fluoropolymer having a node and fibril microstructure and a mean distance between adjacent nodes in the microstructure of about 5 micron or less; and
wherein the blood contact surface includes a coating.

### Claim 18 (depends on 17)

The blood contact surface of claim 17 wherein the coating comprises a therapeutic agent.

### Claim 19 (depends on 17)

The blood contact surface of claim 17 wherein the coating comprises covalently bonded heparin.

### Claim 20 (depends on 17)

The blood contact surface of claim 17 wherein the coating comprises paclitaxel.

### Claim 21 (depends on 17)

The blood contact surface of claim 17 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 22 (depends on 21)

The blood contact surface of claim 21 wherein the fluoropolymer is expanded.

### Claim 23 (depends on 17)

The blood contact surface of claim 17 wherein the fluoropolymer comprises an electrospun fluoropolymer.

### Claim 24

A blood contact surface comprising
a fluoropolymer having a biaxially distributed node and fibril microstructure and a mean distance between adjacent nodes in the microstructure;
wherein the mean distance between adjacent nodes in the microstructure is less than about 5 micron; and
wherein the blood contact surface presents a morphology that allows endothelial cells to attach to the node and fibril microstructure.

### Claim 25 (depends on 24)

The blood contact surface of claim 24 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 26 (depends on 24)

The blood contact surface of claim 24 wherein the endothelial cells attach directly to the node and fibril microstructure without the presence of intervening natural fibrin.

### Claim 27 (depends on 26)

The blood contact surface of claim 26 wherein the fluoropolymer comprises an electrospun polymer.

### Claim 28 (depends on 27)

The blood contact surface of claim 27 wherein the electrospun polymer comprises a fluoropolymer.

### Claim 29

An implantable medical device, comprising
a fluoropolymer having a micro structure of nodes and fibrils and having a first surface and a second surface, wherein the mean distance between adjacent nodes in at least one surface is less than 5 micron, and
wherein the fluoropolymer comprises both the first surface and the second surface of the medical device.

### Claim 30 (depends on 29)

The implantable medical device of claim 29 wherein the fluoropolymer comprises a unitary structure extending between the first surface and the second surface.

### Claim 31 (depends on 29)

The implantable device of claim 29 wherein a thickness between the first surface and the second surface is less than about 0.2 mm.

### Claim 32 (depends on 31)

The implantable device of claim 31 wherein the thickness is less than about 0.05 mm.

### Claim 33 (depends on 29)

The implantable device of claim 29 wherein the fluoropolymer substantially prevents cellular in-growth.

### Claim 34 (depends on 29)

The implantable device of claim 29 wherein the fluoropolymer is formed into a multi-layered structure.

### Claim 35 (depends on 29)

The implantable device of claim 29 wherein the fluoropolymer comprises a film that has a matrix tensile strength in at least one direction of at least 350 MPa.

### Claim 36 (depends on 29)

The implantable device of claim 29 wherein the implantable device includes a blood contact surface that comprises the fluoropolymer.

### Claim 37 (depends on 36)

The implantable device of claim 36 wherein the implantable device comprises a blood contact surface formed from multiple layers of the fluoropolymer.

### Claim 38 (depends on 29)

The blood contact surface of claim 29 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 39

A blood conduit comprising
a polymer tube having a microstructure comprising nodes and fibrils and the microstructure having an mean internodal distance of less than about 5 micron,
wherein the microstructure presents a morphology that allows endothelial cells to attach to the microstructure.

### Claim 40 (depends on 39)

The blood conduit of claim 39 wherein the polymer tube comprises a fluoropolymer.

### Claim 41 (depends on 40)

The blood conduit of claim 40 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 42 (depends on 41)

The blood conduit of claim 41 wherein the polytetrafluoroethylene comprises expanded polytetrafluoroethylene.

### Claim 43

An implantable medical device, the device having a first surface and a second surface, which comprises
a film comprising polytetrafluoroethylene having a node and fibril microstructure and a mean distance between adjacent nodes in the microstructure;
wherein the mean distance between adjacent nodes in the microstructure is less than about 5 micron; and
wherein the film comprises both the first surface and the second surface of the medical device.

### Claim 44 (depends on 43)

The implantable medical device of claim 43 wherein the film comprises a unitary structure extending between the first surface and the second surface.

### Claim 45

A blood contact surface comprising
a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural mammalian fibrin mat.

### Claim 46 (depends on 45)

The blood contact surface of claim 45 wherein the synthetic material comprises a fluoropolymer.

### Claim 47 (depends on 46)

The blood contact surface of claim 46 wherein the fluoropolymer is expanded.

### Claim 48 (depends on 47)

The blood contact surface of claim 47 wherein the expanded fluoropolymer comprises expanded polytetrafluoroethylene.

### Claim 49 (depends on 47)

The blood contact surface of claim 47 wherein the expanded fluoropolymer comprises fibrils and nodes with an average internodal distance of less than about 5 micron.

### Claim 50

A blood contact surface comprising
a fluoropolymer having a node and fibril microstructure substantially as shown in FIG. 4.

### Claim 51 (depends on 50)

The blood contact surface of claim 50 wherein the fluoropolymer comprises copolymers of tetrafluoroethylene.

### Claim 52 (depends on 50)

The blood contact surface of claim 50 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 53 (depends on 50)

An implantable medical device that comprises the blood contact surface of claim 50.

### Claim 54

A blood contact surface comprising
a fluoropolymer having a node and fibril microstructure morphology substantially as shown in FIG. 5.

### Claim 55 (depends on 54)

The blood contact surface of claim 54 wherein the fluoropolymer comprises copolymers of tetrafluoroethylene.

### Claim 56 (depends on 54)

The blood contact surface of claim 54 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 57 (depends on 54)

An implantable medical device that comprises the blood contact surface of claim 54.

### Claim 58

A blood contact surface comprising
a fluoropolymer having a node and fibril microstructure morphology substantially as shown in FIG. 22.

### Claim 59 (depends on 58)

The blood contact surface of claim 58 wherein the fluoropolymer comprises copolymers of tetrafluoroethylene.

### Claim 60 (depends on 58)

The blood contact surface of claim 58 wherein the fluoropolymer comprises polytetrafluoroethylene.

### Claim 61 (depends on 58)

An implantable medical device that comprises the blood contact surface of claim 58.

### Claim 62

A blood contact surface comprising
an expanded polytetrafluoroethylene microstructure of nodes and fibrils extending in both an x direction and a substantially perpendicular y direction;
wherein the microstructure comprises nodes and fibrils with an average distance between adjacent nodes of 5 micron or less; and
wherein the microstructure has a mean fibril orientation of 20 to 70 degrees in a sampling of 32 widest fibrils in a 10,000×SEM micrograph.

### Claim 63 (depends on 62)

The blood contact surface of claim 62 wherein the mean fibril orientation is between 30 to 60 degrees.

### Claim 64

A biocompatible surface comprising
an expanded fluoropolymer having a node and fibril microstructure;
wherein the microstructure comprises a mean internodal distance of less than about 5 micron; and
wherein the mean width of the 32 largest nodes in a representative 10,000×SEM micrograph is less than about 1.5 micron.

### Claim 65

An implantable medical device, comprising
a fluoropolymer having a micro structure of nodes and fibrils and having a first surface and a second surface, wherein the mean distance between adjacent nodes in at least one surface is less than 5 micron, and
wherein the fluoropolymer includes a seam.

### Claim 66 (depends on 65)

The implantable medical device of claim 65 that further comprises the seam extending between the first surface to the second surface.

### Claim 67 (depends on 66)

The implantable medical device of claim 66 wherein the fluoropolymer having a first and second surface and a seam is combined with at least one additional layer of biomaterial to form the medical device.

### Claim 68 (depends on 64)

The implantable medical device of claim 64 that further comprises the fluoropolymer comprises both the first surface and the second surface of the medical device.

### Claim 69

A blood contact surface comprising
an expanded polytetrafluoroethylene microstructure of nodes and fibrils in both an x direction and in a substantially perpendicular y direction;
wherein the nodes and fibrils have a mean distance between adjacent nodes of 5 micron or less; and
wherein the mean width of the 32 longest fibrils in a representative 10,000×SEM micrograph is less than about 0.3 micron.

### Claim 70

A blood contact surface comprising
a polymer having a node and fibril microstructure and a mean distance between adjacent nodes in the microstructure of about 5 micron or less; and
wherein the blood contact surface includes a coating.

### Claim 71 (depends on 70)

The blood contact surface of claim 70 wherein the polymer comprises nylon.

### Claim 72 (depends on 70)

The blood contact surface of claim 70 wherein the polymer comprises polytetrafluoroethylene.

### Claim 73

An implantable blood contact surface that comprises
a biomaterial having a node and fibril microstructure and a thickness;
wherein the microstructure has an internodal distance of less than 5 micron; and
wherein the blood contact surface further includes a series of micro-perforations formed through its thickness.

### Claim 74 (depends on 73)

The blood contact surface of claim 73 wherein the micro-perforations are formed by lasing.
